NIH Grant Awarded

Snowdon was awarded a grant for $628,000 over two years by the U.S. National Institutes of Health (NIH) to develop novel therapies for toxoplasmosis, a serious parasitic disease that affects immuno-compromised individuals such as HIV infected patients and organ transplant recipients. The Company is collaborating on this project with Rima McLeod, M.D., a distinguished clinician-scientist at the University of Chicago Medical Center.